BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36876244)

  • 1. Hypercholesterolemia due to lipoprotein-X manifesting as pseudohyponatremia in a patient with cholestasis.
    Azad F; Mughaedh NA; Alloghbi A; Tawhari I
    Proc (Bayl Univ Med Cent); 2023; 36(2):222-223. PubMed ID: 36876244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudohyponatremia Secondary to Hypercholesterolemia in the Setting of Intrahepatic Cholestasis due to Metastatic Liver Disease: A Case Report and Review of the Literature.
    Pourafkari L; Cavalieri C; Yavari SK; Nader ND
    Acta Med Acad; 2022 Aug; 51(2):128-131. PubMed ID: 36318005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of therapeutic plasma exchange to remove lipoprotein X in a patient with vanishing bile duct syndrome presenting with cholestasis, pseudohyponatremia, and hypercholesterolemia: A case report and review of literature.
    Jung Y; Nelson HA; Lin DM
    J Clin Apher; 2024 Feb; 39(1):e22105. PubMed ID: 38334173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extreme hypercholesterolemia presenting with pseudohyponatremia - a case report and review of the literature.
    Hussain I; Ahmad Z; Garg A
    J Clin Lipidol; 2015; 9(2):260-4. PubMed ID: 25911084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudohyponatremia in acute liver disease.
    Vo H; Gosmanov AR; Garcia-Rosell M; Wall BM
    Am J Med Sci; 2013 Jan; 345(1):62-4. PubMed ID: 23232812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PSEUDOHYPONATREMIA IN THE SETTING OF HYPERCHOLESTEROLEMIA.
    El Hage L; Reineks E; Nasr C
    AACE Clin Case Rep; 2019; 5(2):e172-e174. PubMed ID: 31967027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factitious hyponatremia in a patient with cholestatic jaundice following bone marrow transplantation.
    Coakley JC; Vervaart PP; McKay MR
    Pathology; 1986 Jan; 18(1):158-9. PubMed ID: 3523399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe hypercholesterolemia associated with decreased hepatic triglyceride lipase activity and pseudohyponatremia in patients after allogeneic stem cell transplantation.
    Inamoto Y; Teramoto T; Shirai K; Tsukamoto H; Sanda T; Miyamura K; Yamamori I; Hirabayashi N; Kodera Y
    Int J Hematol; 2005 Nov; 82(4):362-6. PubMed ID: 16298832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of pulmonary hyalinizing granuloma characterized by pseudohyponatremia due to hyperproteinemia.
    Yamauchi M; Kamejima S; Yamamoto I; Ohkido I; Araya J; Yokoo T
    Respir Med Case Rep; 2023; 43():101854. PubMed ID: 37124054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein-X: A Case of Falsely Elevated LDL Hypercholesterolemia.
    Mok JY; Burkle J
    JACC Case Rep; 2023 May; 13():101799. PubMed ID: 37077762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe hypercholesterolemia mediated by lipoprotein X in patients with chronic graft-versus-host disease of the liver.
    Turchin A; Wiebe DA; Seely EW; Graham T; Longo W; Soiffer R
    Bone Marrow Transplant; 2005 Jan; 35(1):85-9. PubMed ID: 15531904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein-X in patients with cirrhosis: its relationship to cholestasis and hypercholesterolemia.
    Sörös P; Böttcher J; Maschek H; Selberg O; Müller MJ
    Hepatology; 1998 Nov; 28(5):1199-205. PubMed ID: 9794902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple lipoprotein and electrolyte laboratory artifacts caused by lipoprotein X in obstructive biliary cholestasis secondary to pancreatic cancer.
    Sivakumar T; Chaidarun S; Lee HK; Cervinski M; Comi R
    J Clin Lipidol; 2011; 5(4):324-8. PubMed ID: 21784379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of lipoprotein-X in the pathogenesis of cholestatic hypercholesterolemia. Uptake of lipoprotein-X and its effect on 3-hydroxy-3-methylglutaryl coenzyme A reductase and chylomicron remnant removal in human fibroblasts, lymphocytes, and in the rat.
    Walli AK; Seidel D
    J Clin Invest; 1984 Sep; 74(3):867-79. PubMed ID: 6470142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudohyponatremia: A Concise Guide to Diagnosis and Management in Clinical Practice.
    Ballard M; Chen L
    J Nurse Pract; 2023; 19(10):. PubMed ID: 38854407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudohyponatremia in a patient with HIV and hepatitis C coinfection.
    Garibaldi BT; Cameron SJ; Choi M
    J Gen Intern Med; 2008 Feb; 23(2):202-5. PubMed ID: 17994269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudohyponatremia: Mechanism, Diagnosis, Clinical Associations and Management.
    Aziz F; Sam R; Lew SQ; Massie L; Misra M; Roumelioti ME; Argyropoulos CP; Ing TS; Tzamaloukas AH
    J Clin Med; 2023 Jun; 12(12):. PubMed ID: 37373769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guillain-Barré syndrome hyponatremia: is it SIADH or pseudohyponatremia?
    Zemke AM; Boles LH; Gillespie M; Viljoen JM
    Oxf Med Case Reports; 2018 Jul; 2018(7):omy042. PubMed ID: 30090635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controversy over the atherogenicity of lipoprotein-X.
    Miida T; Hirayama S
    Curr Opin Endocrinol Diabetes Obes; 2019 Apr; 26(2):117-123. PubMed ID: 30694826
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.